All updates
All updates
today 47中文产业新闻Chinese source评分6060
顶刊论文（社媒热度）评分3131 Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.
文献与产业新闻评分2323 Bausch + Lomb flops in ph. 2 with Xiidra and Miebo but advances combo to ph. 3
顶刊论文（社媒热度）评分4141 Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.
文献与产业新闻评分3535 Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study
顶刊论文（社媒热度）精选评分6262 Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.
顶刊论文（社媒热度）精选评分7575 Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
中文产业新闻精选Chinese source评分6969 Moderna 个体化新抗原疗法 INTerpath-001 三期顶线阳性，国内仍处 I/II 期
中文产业新闻精选Chinese source评分7070 CARTITUDE-4更新分析：西达基奥仑赛在来那度胺耐药多发性骨髓瘤中PFS与OS同步改善
中文产业新闻Chinese source评分6666 Moderna mRNA 个性化肿瘤疫苗联合 K 药黑色素瘤辅助 III 期阳性读数，相关板块情绪波动
文献与产业新闻精选评分7070 STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
文献与产业新闻精选评分6767 STAT+: Inside Moderna and Merck’s cancer vaccine triumph
文献与产业新闻评分4242 A case of Bundibugyo virus disease treated with monoclonal antibodies and remdesivir
文献与产业新闻评分3030 Clinical Outcomes of Multi-Hole Covered Self-Expandable Metal Stents for Malignant Distal Biliary Obstruction: A Retrospective Comparative Study With an Exploratory Evaluation of 6-mm Devices
顶刊论文（社媒热度）评分5858 Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure: The RAFT Clinical Trial.
中文产业新闻Chinese source评分6363 Moderna 与默沙东个体化 mRNA 新抗原疫苗 intismeran autogene 联合帕博利珠单抗 III 期 INTerpath-001 达主要终点
顶刊论文（社媒热度）精选评分8888 Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.
中文产业新闻精选Chinese source评分7070 Moderna 与默沙东联合宣布 mRNA 黑色素瘤疫苗 intismeran autogene 三期 INTerpath-001 达 RFS 与 DMFS 双终点
中文产业新闻Chinese source评分6767 Moderna与默沙东公布mRNA-4157联合K药黑色素瘤辅助治疗Ⅲ期数据 同时达到RFS和DMFS终点
中文产业新闻Chinese source评分6060 mRNA-4157/V940 联合 K 药黑色素瘤辅助治疗 III 期达阳性终点
文献与产业新闻评分3737 Scientists deploy Merck’s Ebola vaccine in DRC
中文产业新闻精选Chinese source评分7979 Moderna与默沙东联合宣布intismeran联合KEYTRUDA辅助治疗黑色素瘤III期试验达到RFS与DMFS双终点
中文产业新闻精选Chinese source评分7272 Moderna新抗原疫苗intismeran autogene联合KEYTRUDA三期阳性，股价单夜涨160%
顶刊论文（社媒热度）精选评分7171 Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.
顶刊论文（社媒热度）精选评分6666 Head positioning after endovascular therapy for acute stroke due to large vessel occlusion (HeadSOAR): multicentre randomised controlled trial.
顶刊论文（社媒热度）精选评分7878 Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.
文献与产业新闻评分3131 Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’
中文产业新闻精选Chinese source评分6868 intismeran autogene联合K药三期达主要终点：Moderna市值暴涨，BioNTech退场
中文产业新闻精选Chinese source评分7676 默沙东与Moderna的mRNA肿瘤疫苗III期达主要终点，显著降低黑色素瘤复发及转移风险
中文产业新闻精选Chinese source评分7777 个性化新抗原 mRNA 癌症疫苗联合 Keytruda Ⅲ 期达 RFS 主要终点，将申报上市
中文产业新闻精选Chinese source评分7676 Moderna 个性化 mRNA 肿瘤疫苗 INTerpath-001 三期随机对照试验取得阳性结果
中文产业新闻精选Chinese source评分8080 intismeran autogene联合KEYTRUDA黑色素瘤辅助治疗三期达RFS主要终点
中文产业新闻Chinese source评分6565 intismeran autogene 联合 Keytruda 黑色素瘤 Ⅲ 期同时达到 RFS 与 DMFS 主要终点
中文产业新闻精选Chinese source评分7171 Moderna 与默沙东 intismeran 联合帕博利珠单抗黑色素瘤辅助治疗 III 期取得积极顶线结果
中文产业新闻精选Chinese source评分7272 默沙东与Moderna联合宣布intismeran autogene联合KEYTRUDA III期达RFS和DMFS双终点
中文产业新闻Chinese source评分6767 Moderna/默沙东 mRNA-4157 在高危术后黑色素瘤 III 期达阳性
中文产业新闻精选Chinese source评分8282 Moderna癌症疗法III期INTerpath-001试验在黑色素瘤中达到无复发生存期主要终点
中文产业新闻Chinese source评分6161 艾尔普 iPSC 心肌细胞疗法治疗重度心衰长期随访结果在《Nature Medicine》发表
中文产业新闻Chinese source评分6161 Moderna与默沙东mRNA癌症疫苗Intismeran三期INTerpath-001达到主要终点
中文产业新闻Chinese source评分6363 Moderna个体化mRNA癌症疫苗III期成功后股价单日暴涨177%